It’s not a stock that’s been in anyone’s forethought for some time. In fact, Calyx Bio-Ventures (CYX.V) isn’t even in the bio-science business anymore, and yesterday you could have bought the entire company for the cost of a Saskatchewan condo.

Today? Two condos. Hey, it’s a start.

Normally I wouldn’t comment much on a largely dormant stock moving from $0.015 to $0.035, because a largely dormant stock usually doesn’t take much buying to bounce about.

But Calyx had moved 3 million shares by breakfast today. By lunch? 4.5 million. Something’s going on.

This isn’t a surprise to me. I had lunch with the CEO a few months back and he talked a lot about his plans to take the company’s ‘Cannigisitics’ software platform and diversify it to other industries outside of marijuana. He’s already done this by putting together a version aimed at commercial real estate management, currently being employed by the owners of Vancouver’s soon-to-be-opened Trump Tower.

But I’ve heard rumblings that Calyx, in building out Cannigisitics, has developed a tool that could be spun out into something bigger.

I don’t have specifics, and CEO Roger Forde, when I called yesterday, wasn’t saying anything other than, “I can maybe demo you what we’re working on in a few weeks.”

Does someone in the Calyx team know enough to start eating stock in advance of news? Has there been a leak? Is it maybe Forde himself doing the buying?

Calyx has seen false starts before and there’s no doubt the company is a microcap in every sense of the word. But when your market cap is under $800k – after a 4 million share trading day – it seems to me there might be some value there.


— Chris Parry

Written By:

Chris Parry

A multi-Webster Award winner for excellence in BC journalism, Parry is the founder and publisher of Equity.Guru, which he built with the specific plan to blend old school reporting with stock promotion, in a way that puts the emphasis on truth, high standards, and ethics. Parry is a veteran of TV, radio, and print, and consults with public companies to help them figure out their storylines, lay down achievable milestones, and improve their communication with shareholders, while also posting regular deep dive analysis of companies in the public spotlight.

More By This Author
Calyx Ventures
0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x